Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death

Journal of Cellular Physiology

Volumn 203, Issue 1, 2005, Pages 127-132

  Chen, George G ^a   Sin, Fanny L F ^a   Leung, Billy C S ^a   Ng, Ho K ^a   Poon, Wai S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; FAS ANTIGEN; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; DNA REPAIR; DNA STRAND BREAKAGE; GLIOBLASTOMA; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GLIOBLASTOMA; HUMANS; IN SITU NICK-END LABELING; INDICATORS AND REAGENTS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; PROPIDIUM; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE;

EID: 14744272755     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20230     Document Type: Article

References (47)

1. Achanta G, Pelicano H, Feng L, Plunkett W, Huang P. 2001. Interaction of p53 and DNA-PK in response to nucleoside analogues: Potential role as a sensor complex for DNA damage. Cancer Res 61:8723-8729.
2. Allalunis-Turner MJ, Barron GM, Day RS III, Dobler KD, Mirzayans R. 1993. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134:349-354.
3. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. 2001. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553-1557.
4. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD. 2002. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 62:6205-6210.
5. Chakravarthy BR, Walker T, Rasquinha I, Hill IE, MacManus JP. 1999. Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. J Neurochem 72:933-942.
6. Chechlacz M, Vemuri MC, Naegele JR. 2001. Role of DNA-dependent protein kinase in neuronal survival. J Neurochem 78:141-154.
7. Chen ZP, McQuillan A, Mohr G, Panasci LC. 1998. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines. Neurosurgery 42:1112-1119.
8. Chen GG, Chak EC, Chun YS, Lam IK, Sin FL, Leung BC, Ng HK, Poon WS. 2003. Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways. J Lab Clin Med 141:190-199.
9. Espejel S, Franco S, Sgura A, Gae D, Bailey SM, Taccioli GE, Blasco MA. 2002. Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J 21:6275-6287.
10. Falchetti ML, Pallini R, D'Ambrosio E, Pierconti F, Martini M, Cimino-Reale G, Verna R, Maira G, Larocca LM. 2000. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme. Int J Cancer 88:895-901.
11. Galloway AM, Allalunis-Turner J. 2000. cDNA expression array analysis of DNA repair genes in human glioma cells that lack or express DNA-PK. Radiat Res 154:609-615.
12. Gurley KE, Kemp CJ. 1996. p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis 17:2537-2542.
13. Gurley KE, Vo K, Kemp CJ. 1998. DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice. Cancer Res 58:3111-3115.
14. Hahn WC. 2003. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21:2034-2043.
15. Harada K, Kurisu K, Sadatomo T, Tahara H, Tahara E, Ide T, Tahara E. 2000. Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity. J Neurooncol 47:39-46.
16. Holgersson A, Jernberg AR, Persson LM, Edgren MR, Lewensohn R, Nilsson A, Brahme A, Meijer AE. 2003. Low and high LET radiatio n-induced apoptosis in M059J and M059K cells. Int J Radiat Biol 79:611-621.
17. Jeggo PA. 1997. DNA-PK: At the cross-roads of biochemistry and genetics. Mutat Res 384:1-14.
18. Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. 2002. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene 21:65-77.
19. Kachnic LA, Wu B, Wunsch H, Mekeel KL, DeFrank JS, Tang W, Powell SN. 1999. The ability of p53 to activate downstream genes p21 (WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase. J Biol Chem 274:13111-13117.
20. Kim JS, He L, Lemasters JJ. 2003. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463-470.
21. Klein A, Miera O, Bauer O, Golfier S, Schriever F. 2000. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle, and DNA repair. Leukemia 14:40-46.
22. Kobayashi T, Ruan S, Jabbur JR, Consoli U, Clodi K, Shiku H, Owen-Schaub LB, Andreeff M, Reed JC, Zhang W. 1998. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ 5:584-591.
23. Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, Cowell JK. 1998. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16:2243-2248.
24. Lee SH, Kim CH. 2002. DNA-dependent protein kinase complex: A multifunctional protein in DNA repair and damage checkpoint. Mol Cell 13:159-166.
25. Lozano J, Menendez S, Morales A, Ehleiter D, Liao WC, Wagman R, Haimovitz-Friedman A, Fuks Z, Kolesnick R. 2001. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J Biol Chem 276:442-448.
26. Mayo LD, Turchi JJ, Berberich SJ. 1997. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res 57:5013-5016.
27. McKeague AL, Wilson DJ, Nelson J. 2003. Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. Br J Cancer 88:125-131.
28. Miyashita T, Harigai M, Hanada M, Reed JC. 1994. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
29. Okaichi K, Suzuki K, Morita N, Ikeda M, Takahashi H, Matsuda N, Watanabe M, Okumura Y. 2002. Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway. Oncology Reports 9:859-862.
30. Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE, McDonnell TJ, Cristiano RJ, Roth JA. 2000. Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res 6:887-890.
31. Pohl U, Wagenknecht B, Naumann U, Weller M. 1999. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis. Cell Physiol Biochem 9:29-37.
32. Reinke V, Lozano G. 1997. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15:1527-1534.
33. Reynolds CP, Maurer BJ, Kolesnick RN. 2004. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169-180.
34. Rimon G, Bazenet CE, Philpott KL, Rubin LL. 1997. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res 48:563-570.
35. Ritchie CK, Giordano A, Khalili K. 2000. Integrin involvement in glioblastoma multiforme: Possible regulation by NF-kappaB. J Cell Physiol 184:214-221.
36. Rothkamm K, Kruger I, Thompson LH, Lobrich M. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23:5706-5715.
37. Shiraishi S, Tada K, Nakamura H, Makino K, Kochi M, Saya H, Kuratsu J, Ushio Y. 2002. Influence of p53 mutations on prognosis of patients with glioblastoma. Cancer 95:249-257.
38. Spencer VA, Davie JR. 2000. Signal transduction pathways and chromatin structure in cancer cells. JJ Cell Biochem Suppl 35:27-35.
39. Studzinski DM, Benjamins JA. 2001. Cyclic AMP differentiation of the oligodendroglial cell line N20.1 switches staurosporine-induced cell death from necrosis to apoptosis. J Neurosci Res 66:691-697.
40. 1 and S phases and correlates with the upregulation of p21 (WAF1/CIP1). J Neurooncol 48:225-232.
41. Tang SJ, Huang YM, Wang FF. 1995. Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation. Biochem J 306:47-56.
42. Tlsty TD, White A, Livanos E, Sage M, Roelofs H, Briot A, Poulose B. 1994. Genomic integrity and the genetics of cancer. Cold Spring Harb Symp Quant Biol 59:265-275.
43. Virsik-Kopp P, Rave-Frank M, Hofman-Huther H, Schmidberger H. 2003. Role of DNA-PK in the process of aberration formation as studied in irradiated human glioblastoma cell lines M059K and M059J. Int J Radiat Biol 79:61-68.
44. Weber RG, Rieger J, Naumann U, Lichter P, Weller M. 2001. Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines. Int J Cancer 91:213-218.
45. Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, Lee PW. 2002. DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. EMBO J 21:3000-3008.
46. Yamagishi N, Miyakoshi J, Takebe H. 1997. Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. Int J Radiat Biol 72:157-162.
47. Yang J, Yu Y, Hamrick HE, Duerksen-Hughes PJ. 2003. ATM, ATR, and DNA-PK: Initiators of the cellular genotoxic stress responses. Carcinogenesis 24:1571-1580.